2014•Unpublished venueRequires access

Effect of Azithromycin on IgA,IgG,IgM levels and T lymphocyte subsets in children with Mycoplasma pneumoniae pneumonia

Lang Chen

Open publisher page 0 citations

Abstract

Objective: To analyze the effect of Azithromycin on IgA,IgG,IgM levels and T lymphocyte subsets( TLS) in children with Mycoplasma pneumoniae pneumonia( MPP). Methods: Eighty- six MPP children were selected as study objects,and then they were divided into observation group( 43 children) and control group( 43 children) according to random number table; the children in control group were treated with Erythromycin,while the children in observation group were treated with Azithromycin; immunoglobulins and TLS before and after treatment in the two groups were compared. Results: The levels of serum IgG and IgM in observation group after treatment were( 10. 37 ± 2. 38) g /L and( 1. 74 ± 0. 22) g /L,respectively,which were statistically significantly lower than those before treatment( 12.60 ±3.45) g/L and( 1.99 ±0.34) g/L,respectively( P 0.05); after treatment,serum IgG and IgM levels in observation group were statistically significantly lower than those in control group( P 0. 05); after treatment,serum IgA levels in observation group and control group were( 0. 91 ± 0. 33) g /L and( 0. 92 ± 0. 23) g /L,respectively,compared with before treatment( 0. 93 ± 0. 47) g /L and( 0. 94 ±0. 52) g /L,there was no statistically significant difference( P 0. 05); in observation group,the level of CD4 + and CD4 + /CD8 + ratio after treatment were( 46. 38 ± 5. 07) and( 1. 45 ± 0. 25),respectively,which were statistically significantly higher than those before treatment( 41. 77 ± 5. 34 and 1. 21 ± 0. 45) and after treatment in control group( 44. 12 ± 5. 18 and 1. 34 ± 0. 23)( P 0. 05); CD8 + level after treatment in observation group was( 30. 12 ± 4. 13),which was statistically significantly lower than that before treatment in observation group( 34. 67 ± 6. 04) and after treatment in control group( 32. 10 ± 4. 56)( P 0. 05). Conclusion: Azithromycin can significantly improve immunoglobulin levels of MPP children,optimize TLS situation and the curative effect is significant,which is worth clinical popularizing.

About this research paper

What this paper is about

Objective: To analyze the effect of Azithromycin on IgA,IgG,IgM levels and T lymphocyte subsets( TLS) in children with Mycoplasma pneumoniae pneumonia( MPP). Methods: Eighty- six MPP children were selected as study objects,and then they were divided into observation group( 43 children) and control group( 43 children) according to random number table; the children in control group were treated with Erythromycin,while the children in observation group were treated with Azithromycin; immunoglobulins and TLS before and after treatment in the two groups were compared. Results: The levels of serum IgG and IgM in observation group after treatment were( 10. 37 ± 2. 38) g /L and( 1. 74 ± 0. 22) g /L,respectively,which were statistically significantly lower than those before treatment( 12.60 ±3.45) g/L and( 1.99 ±0.34) g/L,respectively( P 0.05); after treatment,serum IgG and IgM levels in observation group were statistically significantly lower than those in control group( P 0. 05); after treatment,serum IgA levels in observation group and control group were( 0. 91 ± 0. 33) g /L and( 0. 92 ± 0. 23) g /L,respectively,compared with before treatment( 0. 93 ± 0. 47) g /L and( 0. 94 ±0. 52) g /L,there was no statistically significant difference( P 0. 05); in observation group,the level of CD4 + and CD4 + /CD8 + ratio after treatment were( 46. 38 ± 5. 07) and( 1. 45 ± 0. 25),respectively,which were statistically significantly higher than those before treatment( 41. 77 ± 5. 34 and 1. 21 ± 0. 45) and after treatment in control group( 44. 12 ± 5. 18 and 1. 34 ± 0. 23)( P 0. 05); CD8 + level after treatment in observation group was( 30. 12 ± 4. 13),which was statistically significantly lower than that before treatment in observation group( 34. 67 ± 6. 04) and after treatment in control group( 32. 10 ± 4. 56)( P 0. 05). Conclusion: Azithromycin can significantly improve immunoglobulin levels of MPP children,optimize TLS situation and the curative effect is significant,which is worth clinical popularizing.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To analyze the effect of Azithromycin on IgA,IgG,IgM levels and T lymphocyte subsets( TLS) in children with Mycoplasma pneumoniae pneumonia( MPP). Methods: Eighty- six MPP children were selected as study objects,and then they were divided into observation group( 43 children) and control group( 43 children) according to random number table; the children in control group were treated with Erythromycin,while the children in observation group were treated with Azithromycin; immunoglobulins and TLS before and after treatment in the two groups were compared. Results: The levels of serum IgG and IgM in observation group after treatment were( 10. 37 ± 2. 38) g /L and( 1. 74 ± 0. 22) g /L,respectively,which were statistically significantly lower than those before treatment( 12.60 ±3.45) g/L and( 1.99 ±0.34) g/L,respectively( P 0.05); after treatment,serum IgG and IgM levels in observation group were statistically significantly lower than those in control group( P 0. 05); after treatment,serum IgA levels in observation group and control group were( 0. 91 ± 0. 33) g /L and( 0. 92 ± 0. 23) g /L,respectively,compared with before treatment( 0. 93 ± 0. 47) g /L and( 0. 94 ±0. 52) g /L,there was no statistically significant difference( P 0. 05); in observation group,the level of CD4 + and CD4 + /CD8 + ratio after treatment were( 46. 38 ± 5. 07) and( 1. 45 ± 0. 25),respectively,which were statistically significantly higher than those before treatment( 41. 77 ± 5. 34 and 1. 21 ± 0. 45) and after treatment in control group( 44. 12 ± 5. 18 and 1. 34 ± 0. 23)( P 0. 05); CD8 + level after treatment in observation group was( 30. 12 ± 4. 13),which was statistically significantly lower than that before treatment in observation group( 34. 67 ± 6. 04) and after treatment in control group( 32. 10 ± 4. 56)( P 0. 05). Conclusion: Azithromycin can significantly improve immunoglobulin levels of MPP children,optimize TLS situation and the curative effect is significant,which is worth clinical popularizing.

Key concepts: Azithromycin, Medicine, Mycoplasma pneumoniae, Mycoplasma pneumonia, Immunology, CD8, Internal medicine, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Azithromycin on IgA,IgG,IgM levels and T lymphocyte subsets in children with Mycoplasma pneumoniae pneumonia — Research Paper | ScholarLens